Dave Moore, senior vice president of U.S. operations at Novo Nordisk, says his company wants to “meet patients where they are ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer ... of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499. All doses will be delivered ...

The companies will sell the ... the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Hims & Hers Health, Inc. just announced a partnership with Novo Nordisk, Ro and LifeMD to sell ... GLP-1 brand injections such as Ozempic and Wegovy, which came with a whopping price tag that's ...

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy ... more customers. Telehealth provider Ro in late 2024 began selling Lilly's ...

Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as ...